Benzinga | Oct 26, 2021 09:23AM EDT

Jefferies Initiates Coverage On Roivant Sciences with Buy Rating, Announces Price Target of $10

Jefferies analyst Dennis Ding initiates coverage on Roivant Sciences (NASDAQ:ROIV) with a Buy rating and announces Price Target of $10.